New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization
2021/43/D/NZ7/00622
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ5_007: Leczenie chorób człowieka
- NZ1_009: Biotechnologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
dr Anna Katarzyna Florczak-Substyk
Number of co-investigators in the project: 4
Call
SONATA 17 – announced on 2021-09-15
- Amount awarded
- 1 899 103 PLN
- Project start date
- 2022-09-26
- Project end date
- 2027-09-25
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway
- Authors:
- Patryk Lorenc, Agata Sikorska, Sara Molenda, Natalia Guzniczak, Hanna Dams-Kozlowska, Anna Florczak
- Academic press:
- Biomedicine & Pharmacotherapy (year: 2024, volume: 180, pages: 117585), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.biopha.2024.117585 – link to the publication